Your browser doesn't support javascript.
loading
Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles.
Minciacchi, Valentina R; You, Sungyong; Spinelli, Cristiana; Morley, Samantha; Zandian, Mandana; Aspuria, Paul-Joseph; Cavallini, Lorenzo; Ciardiello, Chiara; Reis Sobreiro, Mariana; Morello, Matteo; Kharmate, Geetanjali; Jang, Su Chul; Kim, Dae-Kyum; Hosseini-Beheshti, Elham; Tomlinson Guns, Emma; Gleave, Martin; Gho, Yong Song; Mathivanan, Suresh; Yang, Wei; Freeman, Michael R; Di Vizio, Dolores.
Afiliação
  • Minciacchi VR; Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • You S; Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Spinelli C; Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Morley S; The Urological Diseases Research Center, Boston Children's Hospital, Boston, MA, USA.
  • Zandian M; Department of Surgery, Harvard Medical School, Boston, MA, USA.
  • Aspuria PJ; Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Cavallini L; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Ciardiello C; Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Reis Sobreiro M; Department of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
  • Morello M; Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Kharmate G; Experimental Pharmacology Unit, Department of Research, IRCCS-Istituto Nazionale Tumori G. Pascale, Naples, Italy.
  • Jang SC; Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Kim DK; Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Hosseini-Beheshti E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, BC, Canada.
  • Tomlinson Guns E; Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.
  • Gleave M; Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.
  • Gho YS; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, BC, Canada.
  • Mathivanan S; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, BC, Canada.
  • Yang W; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, BC, Canada.
  • Freeman MR; Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.
  • Di Vizio D; Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Australia.
Oncotarget ; 6(13): 11327-41, 2015 May 10.
Article em En | MEDLINE | ID: mdl-25857301
ABSTRACT
Large oncosomes (LO) are atypically large (1-10 µm diameter) cancer-derived extracellular vesicles (EVs), originating from the shedding of membrane blebs and associated with advanced disease. We report that 25% of the proteins, identified by a quantitative proteomics analysis, are differentially represented in large and nano-sized EVs from prostate cancer cells. Proteins enriched in large EVs included enzymes involved in glucose, glutamine and amino acid metabolism, all metabolic processes relevant to cancer. Glutamine metabolism was altered in cancer cells exposed to large EVs, an effect that was not observed upon treatment with exosomes. Large EVs exhibited discrete buoyant densities in iodixanol (OptiPrep(TM)) gradients. Fluorescent microscopy of large EVs revealed an appearance consistent with LO morphology, indicating that these structures can be categorized as LO. Among the proteins enriched in LO, cytokeratin 18 (CK18) was one of the most abundant (within the top 5th percentile) and was used to develop an assay to detect LO in the circulation and tissues of mice and patients with prostate cancer. These observations indicate that LO represent a discrete EV type that may play a distinct role in tumor progression and that may be a source of cancer-specific markers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Micropartículas Derivadas de Células / Proteínas de Neoplasias Limite: Animals / Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Micropartículas Derivadas de Células / Proteínas de Neoplasias Limite: Animals / Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos